Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Auton Autacoid Pharmacol ; 23(5-6): 307-17, 2003.
Article in English | MEDLINE | ID: mdl-15255815

ABSTRACT

1. In the present investigation we examined the regulation of calmodulin (CaM)- and protein kinase C (PKC)-dependent pathways by cytosolic Ca(2+) in the contraction of cat lower oesophageal sphincter (LES). 2. Force developed in response to increasing doses of acetylcholine (ACh) was directly related to the increase of the [Ca(2+)](i) measured by fura-2. Thapsigargin, which depletes Ca(2+) stores, reduced the contraction and the [Ca(2+)](i). In addition, contraction in response to maximal ACh was reduced by the CaM inhibitor CGS9343B but not by the PKC inhibitor chelerythrine. The contraction in response to submaximal ACh was reduced by chelerythrine but not by CGS9343B. 3. In permeabilized cells, the contraction in response to low Ca(2+) (0.54 microm) was also reduced by CGS9343B. 4. The response to high Ca(2+) (1.0 microm) was reduced by CGS9343B. ACh also inhibited PKC activation induced by diacylglycerol, which activation is inhibited by the N-myristoylated peptide inhibitor derived from pseudosubstrate sequences of PKCalphabetagamma (myr-PKC-alphabetagamma), but not of myr-PKC-alpha. 5. These data are consistent with the view that activated CaM-dependent pathways inhibit PKC-dependent pathways, this switch mechanism might be regulated by Ca(2+) in the LES.


Subject(s)
Calcium/physiology , Calmodulin/physiology , Esophagogastric Junction/physiology , Protein Kinase C/physiology , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Acetylcholine/antagonists & inhibitors , Acetylcholine/pharmacology , Alkaloids , Animals , Benzimidazoles/pharmacology , Benzophenanthridines , Calcium/antagonists & inhibitors , Calcium/chemistry , Calmodulin/chemistry , Cats , Cell Membrane Permeability/drug effects , Cell Membrane Permeability/physiology , Diglycerides/pharmacology , Esophagogastric Junction/cytology , Esophagogastric Junction/drug effects , Inositol 1,4,5-Trisphosphate/pharmacology , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle Relaxation/drug effects , Muscle Relaxation/physiology , Myocytes, Smooth Muscle/cytology , Myocytes, Smooth Muscle/drug effects , Phenanthridines/pharmacology , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/chemistry , Signal Transduction/physiology , Thapsigargin/antagonists & inhibitors , Thapsigargin/pharmacology
2.
J Physiol ; 537(Pt 2): 567-77, 2001 Dec 01.
Article in English | MEDLINE | ID: mdl-11731586

ABSTRACT

1. The present study was undertaken to determine whether calponin (CaP) participates in the regulation of vascular smooth muscle contraction and, if so, to investigate the mechanism. 2. By PCR homology cloning, the cDNA sequence of ferret basic (h1) CaP was determined and phosphorothioate antisense and random oligonucleotides were synthesized and introduced into strips of ferret aorta by a chemical loading procedure. 3. Treatment of ferret aorta with CaP antisense oligonucleotides resulted in a decrease in protein levels of CaP to 54% of that in random sequence-loaded muscles, but no change in the protein levels of caldesmon (CaD), actin, desmin or extracellular regulated protein kinase (ERK). 4. Contraction in response to phenylephrine or a phorbol ester was significantly decreased in antisense-treated muscles compared to random sequence-loaded controls. Neither basal intrinsic tone nor the contraction in response to 51 mM KCl was significantly affected by antisense treatment. 5. During phenylephrine contractions, phospho-ERK levels increased, as did myosin light chain (LC20) phosphorylation. Phenylephrine-induced ERK phosphorylation and CaD phosphorylation at an ERK site were significantly decreased by CaP antisense. Increases in myosin light chain phosphorylation were unaffected. 6. The data indicate that CaP plays a significant role in the regulation of contraction and suggest that in a tonically active smooth muscle CaP may function as a signalling protein to facilitate ERK-dependent signalling, but not as a direct regulator of actomyosin interactions at the myofilament level.


Subject(s)
Calcium-Binding Proteins/physiology , Muscle, Smooth, Vascular/physiology , Signal Transduction/physiology , Adrenergic alpha-Agonists/pharmacology , Amino Acid Sequence/genetics , Animals , Aorta , Base Sequence/genetics , Calcium-Binding Proteins/antagonists & inhibitors , Calcium-Binding Proteins/genetics , DNA, Complementary/genetics , Ferrets , Microfilament Proteins , Mitogen-Activated Protein Kinases/metabolism , Molecular Sequence Data , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Myosin Light Chains/metabolism , Oligonucleotides, Antisense/pharmacology , Organ Culture Techniques , Phenylephrine/pharmacology , Phosphorylation/drug effects , Vasoconstriction/physiology , Vasoconstrictor Agents/pharmacology , Calponins
3.
J Auton Pharmacol ; 21(1): 23-8, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11422575

ABSTRACT

1. Thiols have been implicated to play a role in a variety of aspects of nitric oxide (NO) generation and activity. Thiol dependence of nitric oxide synthase (NOS) has remained controversial and its mechanism is not clear. This study investigates possible mechanisms between thiol (SH group) and NOS activation, through thiol compounds (glutathione, dithiothreitol, N-acetyl-L-cysteine) and Ebselen [2-phenyl-1,2-benzisoselenazole-3(2H)-one] on rat aortic vascular responses. 2. In rat thoracic aorta, acetylcholine (10(-6)-10(-9) M) induced a relaxation of phenylephrine (PE) (10(-7) M)-induced tone, which was inhibited dose dependently by increasing concentration of ebselen (1-10 microM). 3. In rings of rat thoracic aorta, ebselen and NOS inhibitors (NG-monomethyl-L-arginine, NG-nitro-L-arginine methyl ester) produced an augmentation of phenylephrine (10(-7) M)- induced tone and acetylcholine induced a relaxation of PE (10(-7) M)-induced tone in rat thoracic aorta, which was inhibited by ebselen (10 microM) like NOS inhibitor. 4. The thiol compounds (glutathione, dithiothreitol, and N-acetyl-L-cysteine) alone did not change vascular tone in rat thoracic aorta. Pretreatment with thiol compounds before ebselen treatment, however, reversed the inhibitory effect of ebselen which acts like the NOS inhibitor in rat thoracic aorta. Posttreatment with thiol compounds after ebselen treatment did not reverse the inhibitory effect of ebselen by as much as pretreatment. 5. Calcium ionophore A23187 (10(-7) M)-induced vasodilation was inhibited in ebselen pretreated rat thoracic aorta, but sodium nitroprusside (SNP, 10(-7) M)-induced relaxation was not inhibited by ebselen. This suggests that NOS is involved in the inhibitory effect of ebselen on rat thoracic aorta relaxation. 6. These results suggest that ebselen exerts an inhibitory action on the nitric oxide synthesis in rat thoracic aorta by interacting with thiol groups.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Azoles/pharmacology , Muscle, Smooth, Vascular/drug effects , Nitric Oxide/metabolism , Organoselenium Compounds/pharmacology , Sulfhydryl Compounds/pharmacology , Acetylcholine/pharmacology , Adrenergic alpha-Agonists/pharmacology , Animals , Aorta, Thoracic/drug effects , Calcimycin/pharmacology , Drug Interactions , Enzyme Activation , Female , Ionophores/pharmacology , Isoindoles , Muscle Relaxation/drug effects , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Nitroprusside/pharmacology , Phenylephrine/pharmacology , Rats , Rats, Sprague-Dawley , Vasodilation/drug effects , Vasodilator Agents/pharmacology
4.
J Auton Pharmacol ; 21(5-6): 231-6, 2001.
Article in English | MEDLINE | ID: mdl-12123467

ABSTRACT

1 We measured the plasma glucose and the glycosylated haemoglobin at the time of sacrifice in streptozotocin-induced diabetic mellitus (DM) rats. 2 In diabetic rats, plasma glucose and glycosylated haemoglobin was increased as compared with normal rats, and vitamin E inhibited the increase of glycosylated haemoglobin level but vitamin C had no effect. 3 The peroxidized proteins and lipids from the diabetic organs such as liver or kidney were measured to assess the oxidative damage. The 2,4-dinitrophenyl-hydrazine (DNPH) incorporation method was used to measure the peroxidized protein. In diabetic rats, DNPH incorporation was increased as compared with normal rats and vitamin E also inhibited the increase of DNPH incorporation but vitamin C had no effect. It suggests that the protein oxidation occurred on the liver in diabetic rats and the oxidative stress is general in the diabetic condition. 4 We measured the systolic arterial pressure and mean arterial pressure in normal rats, nephrectomy (NEPH)-rats, diabetic rats (DM), and NEPH-diabetic rats (NEPH-DM). Blood pressure was significantly increased in DM and NEPH-DM as compared with normal rats. 5 In conclusion, plasma glucose, glycosylated haemoglobin, and the oxidation of proteins or lipid were increased in diabetic rats. Vitamin E decreased the plasma glucose, glycosylated haemoglobin and the oxidation of proteins and lipid, but vitamin C had no effects.


Subject(s)
Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Diabetes Mellitus, Experimental/metabolism , Proteins/metabolism , Vitamin E/pharmacology , Animals , Lipid Peroxidation , Liver/metabolism , Male , Nephrectomy , Oxidation-Reduction , Rats , Rats, Sprague-Dawley , Streptozocin
5.
J Physiol ; 526 Pt 2: 367-74, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10896725

ABSTRACT

1. The present study was undertaken to determine whether Ca2+-calmodulin-dependent protein kinase II (CaMKII) participates in the regulation of vascular smooth muscle contraction, and if so, to investigate the nature of the downstream effectors. 2. The contractility of isolated ferret aorta was measured while inhibiting CaMKII either with antisense oligodeoxynucleotides against CaMKII or with the CaMKII inhibitor KN93. 3. Treatment with antisense oligodeoxynucleotides against CaMKII resulted in, on average, a decrease in protein levels of CaMKII to 56 % of control levels and significantly decreased the magnitude of the contraction in response to 51 mM potassium physiological saline solution (KCl). Contraction in response to the phorbol ester DPBA was not significantly affected. 4. The CaMKII blocker KN93 also resulted in a significant decrease in the force induced by 51 mM KCl but caused no significant change in the contraction in response to DPBA or the alpha-adrenoceptor agonist phenylephrine. 5. During contraction with 51 mM KCl, both CaMKII and mitogen-activated protein kinase (MAPK) activity increased, as determined by phospho-specific antibodies. The MAPK phosphorylation level was inhibited by KN93, PD098059 (a MAPK kinase (MEK) inhibitor) and calcium depletion. 6. Myosin light chain (LC20) phosphorylation also increased during contraction with KCl and the increase was significantly blocked by PD098059 as well as by both KN93 and antisense oligodeoxynucleotides to CaMKII. 7. The data indicate that CaMKII plays a significant role in the regulation of smooth muscle contraction and suggest that CaMKII activates a pathway by which MAPK activation leads to phosphorylation of LC20 via activation of myosin light chain kinase.


Subject(s)
Aorta, Thoracic/physiology , Benzylamines/pharmacology , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Enzyme Inhibitors/pharmacology , Muscle Contraction/physiology , Muscle, Smooth, Vascular/physiology , Oligodeoxyribonucleotides, Antisense/pharmacology , Sulfonamides/pharmacology , Animals , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Calcium-Calmodulin-Dependent Protein Kinases/genetics , Ferrets , Flavonoids/pharmacology , In Vitro Techniques , Mitogen-Activated Protein Kinases/metabolism , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Myosin Light Chains/metabolism , Phosphorylation , Potassium Chloride/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL